entertainment -WSS

entertainment

author：leisure time 2025-09-30 17:29:59 - browse：16371

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： How to address the problem of discarded donor organs

explore

WSS

International team creates first chimeric human

Fetal cell organoids grown from amniotic fluid, study finds

Scientists unlock the key to scar

In search for therapies for solid tumors, companies turn to claudin

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

RaDonda Vaught to speak at CommonSpirit event on patient safety

focus

entertainment

explore

Drug repurposing or repositioning? The language matters

$1 billion proposal to grow Boston, Massachusetts biotech

Wildfire smoke exposes gaps in outdoor worker protections

Kenai launches with $82 million for Parkinson’s stem cell therapy

Jerome Adams on the need for new antivirals for Covid

FogPharma raises $145 million in rare Series E round

At least 13 dead in Texas as scorching temps continue

An inside look at PIPEs, biotech's buzzy new financing tool

Hepatitis C has a cure — but many Americans still lack access to it

Lack of health data on LGBTQ+ people has serious consequences

leisure time

How to address the problem of discarded donor organs

Families look for replacement for GSK asthma drug Flovent

$1 billion proposal to grow Boston, Massachusetts biotech

An inside look at PIPEs, biotech's buzzy new financing tool

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Fetal cell organoids grown from amniotic fluid, study finds

explore

hotspot

leisure time

hotspot